Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CRYSTAL M PROUD

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1013159177
CMS profile
990357
Location
NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$155,434.78

166 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Sarepta Therapeutics, Inc. $106,666.37 77
Biogen, Inc. $26,948.44 62
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $17,387.72 19
PFIZER INC. $3,766.66 3
F. Hoffmann-La Roche AG $609.12 2
Supernus Pharmaceuticals, Inc. $36.31 2
Genentech USA, Inc. $20.16 1

Page 4 of 4; records 151–166 of 166 matching records. This page contains 16 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CRYSTAL M PROUD

NPI 1013159177 · CMS profile ID 990357

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology with Special Qualifications in Child Neurology

NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–166 of 166 matching records. This page contains 16 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1013159177?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CRYSTAL M PROUD, NPI 1013159177, CMS profile ID 990357. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–166 of 166 matching records. This page contains 16 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1013159177?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). CRYSTAL M PROUD, NPI 1013159177, CMS profile ID 990357. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–166 of 166 matching records. This page contains 16 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1013159177?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
CRYSTAL M PROUD, NPI 1013159177, CMS profile ID 990357, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–166 of 166 matching records. This page contains 16 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1013159177?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

166 matching records · $155,434.78 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 166 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–166 of 166.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sarepta Therapeutics, Inc. $48.0001/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053377575 CMS
Sarepta Therapeutics, Inc. $117.8001/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053375893 CMS
Sarepta Therapeutics, Inc. $84.4601/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053375993 CMS
Sarepta Therapeutics, Inc. $300.0001/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053376013 CMS
Sarepta Therapeutics, Inc. $315.2701/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053376025 CMS
Sarepta Therapeutics, Inc. $1,460.4401/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053376161 CMS
Sarepta Therapeutics, Inc. $9,625.0001/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053376235 CMS
Sarepta Therapeutics, Inc. $11.1401/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053376259 CMS
Sarepta Therapeutics, Inc. $27.1301/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053377493 CMS
Sarepta Therapeutics, Inc. $40.2601/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053377525 CMS
Sarepta Therapeutics, Inc. $48.0001/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053377569 CMS
Sarepta Therapeutics, Inc. $48.7001/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053377589 CMS
Sarepta Therapeutics, Inc. $48.7001/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053377597 CMS
Biogen, Inc. $0.8901/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012207609 CMS
Biogen, Inc. $18.8801/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012220641 CMS
Genentech USA, Inc. $20.1601/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040334229 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $85,860.76 153
PY2020 $71,860.95 85
PY2021 $53,518.40 61
PY2022 $97,744.89 116
PY2023 $155,434.78 166
PY2024 $257,975.97 154
PY2025 $279,590.27 119

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $11,520.46 5
PY2025 Principal investigator $993,690.21 314
PY2024 Recipient $4,416.31 9
PY2024 Principal investigator $1,018,096.66 363
PY2023 Recipient $2,728.41 7
PY2023 Principal investigator $1,418,328.74 414
PY2022 Recipient $1,000.00 2
PY2022 Principal investigator $861,002.84 172
PY2021 Recipient $13,737.07 7
PY2021 Principal investigator $1,336,696.73 92
PY2020 Principal investigator $357,902.35 73
PY2019 Recipient $4,500.00 1
PY2019 Principal investigator $102,799.06 16

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

319 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Sarepta Therapeutics, Inc. $0.06 12/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223615916
Principal investigator 1 Sarepta Therapeutics, Inc. $182.46 12/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223615918
Principal investigator 1 Sarepta Therapeutics, Inc. $0.72 12/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223615920
Principal investigator 1 Sarepta Therapeutics, Inc. $0.84 12/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223615922
Principal investigator 1 Sarepta Therapeutics, Inc. $1,620.00 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614189
Principal investigator 1 Sarepta Therapeutics, Inc. $271.09 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614191
Principal investigator 1 Sarepta Therapeutics, Inc. $120.00 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614193
Principal investigator 1 Sarepta Therapeutics, Inc. $120.00 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614195
Principal investigator 1 Sarepta Therapeutics, Inc. $120.00 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614201
Principal investigator 1 Sarepta Therapeutics, Inc. $271.10 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614203
Principal investigator 1 Sarepta Therapeutics, Inc. $500.00 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614205
Principal investigator 1 Sarepta Therapeutics, Inc. $171.87 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614207
Principal investigator 1 Sarepta Therapeutics, Inc. $271.09 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614209
Principal investigator 1 Sarepta Therapeutics, Inc. $1,620.00 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614211
Principal investigator 1 Sarepta Therapeutics, Inc. $271.09 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614213
Principal investigator 1 Sarepta Therapeutics, Inc. $810.00 12/19/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223615924
Principal investigator 1 Biogen, Inc. $2,765.00 12/18/2025 Covered Recipient Teaching Hospital
Childrens Hospital Of The Kings Da
A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam No dispute reported 06/30/2026 1236947946
Principal investigator 1 Sarepta Therapeutics, Inc. $810.00 12/17/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9005-101 No dispute reported 06/30/2026 1223611795
Principal investigator 1 Sarepta Therapeutics, Inc. $675.00 12/17/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9005-101 No dispute reported 06/30/2026 1223611797
Principal investigator 1 Sarepta Therapeutics, Inc. $337.00 12/17/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9005-101 No dispute reported 06/30/2026 1223611799
Principal investigator 1 Sarepta Therapeutics, Inc. $1,620.00 12/17/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9005-101 No dispute reported 06/30/2026 1223611801
Principal investigator 1 Sarepta Therapeutics, Inc. $1,350.00 12/17/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9005-101 No dispute reported 06/30/2026 1223611803
Principal investigator 1 PTC Therapeutics, Inc. $495.00 12/16/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093842
Principal investigator 1 Sarepta Therapeutics, Inc. $1,883.05 12/11/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614185
Principal investigator 1 Novartis Pharmaceuticals Corporation $135.28 12/08/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
Phase IIIb, Open-label, Single-arm, Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally (1.2 x 10^14 Vector Genomes) to Participants 2 to 12 Years of Age With Spinal Muscular Atrophy (SMA) Who Have Dis No dispute reported 06/30/2026 1190305137
Principal investigator 1 Novartis Pharmaceuticals Corporation $20.00 12/01/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials No dispute reported 06/30/2026 1190305131
Principal investigator 1 Sarepta Therapeutics, Inc. $11,341.16 12/01/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614187
Principal investigator 1 Sarepta Therapeutics, Inc. $11,341.16 12/01/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614197
Principal investigator 1 Sarepta Therapeutics, Inc. $11,341.16 12/01/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614199
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 11/27/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611659
Principal investigator 1 Sarepta Therapeutics, Inc. $248.07 11/13/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610787
Principal investigator 1 Sarepta Therapeutics, Inc. $2,041.20 11/12/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-401 No dispute reported 06/30/2026 1223609723
Recipient Novartis Pharmaceuticals Corporation $286.19 11/06/2025 Covered Recipient Physician STRENGTH No dispute reported 06/30/2026 1190293717
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 11/06/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611651
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 11/06/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611653
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 11/06/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611655
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 11/06/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611657
Principal investigator 1 Sarepta Therapeutics, Inc. $2,422.09 11/06/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611661
Principal investigator 1 Sarepta Therapeutics, Inc. $60.50 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610771
Principal investigator 1 Sarepta Therapeutics, Inc. $0.13 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610773
Principal investigator 1 Sarepta Therapeutics, Inc. $176.64 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610789
Principal investigator 1 Sarepta Therapeutics, Inc. $0.06 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610791
Principal investigator 1 Sarepta Therapeutics, Inc. $0.72 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610793
Principal investigator 1 Sarepta Therapeutics, Inc. $0.84 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610795
Principal investigator 1 Sarepta Therapeutics, Inc. $0.06 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610797
Principal investigator 1 Sarepta Therapeutics, Inc. $19.20 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610799
Principal investigator 1 Sarepta Therapeutics, Inc. $0.92 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610801
Principal investigator 1 Sarepta Therapeutics, Inc. $0.35 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610803
Principal investigator 1 Sarepta Therapeutics, Inc. $16.27 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610805
Principal investigator 1 Sarepta Therapeutics, Inc. $0.28 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610807
Principal investigator 1 Sarepta Therapeutics, Inc. $0.61 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610809
Principal investigator 1 Sarepta Therapeutics, Inc. $4.36 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610811
Principal investigator 1 Sarepta Therapeutics, Inc. $0.27 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610813
Principal investigator 1 Sarepta Therapeutics, Inc. $0.58 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610815
Principal investigator 1 Sarepta Therapeutics, Inc. $0.36 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610817
Principal investigator 1 Sarepta Therapeutics, Inc. $14.96 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613402
Principal investigator 1 Sarepta Therapeutics, Inc. $0.72 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613404
Principal investigator 1 Sarepta Therapeutics, Inc. $0.88 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613406
Principal investigator 1 Sarepta Therapeutics, Inc. $4.50 11/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613408
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 10/31/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223616076
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 10/31/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223616078
Principal investigator 1 Genentech, Inc. $7,218.00 10/28/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
A PHASE II STUDY OF SATRALIZUMAB IN PEDIATRIC PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY No dispute reported 06/30/2026 1211586295
Principal investigator 1 Sarepta Therapeutics, Inc. $8,422.66 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223611805
Principal investigator 1 Sarepta Therapeutics, Inc. $674.00 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223611807
Principal investigator 1 Sarepta Therapeutics, Inc. $648.00 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223611809
Principal investigator 1 Sarepta Therapeutics, Inc. $36.90 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613332
Principal investigator 1 Sarepta Therapeutics, Inc. $6.00 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613334
Principal investigator 1 Sarepta Therapeutics, Inc. $5.40 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613336
Principal investigator 1 Sarepta Therapeutics, Inc. $52.38 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613338
Principal investigator 1 Sarepta Therapeutics, Inc. $46.08 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613340
Principal investigator 1 Sarepta Therapeutics, Inc. $22.02 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613342
Principal investigator 1 Sarepta Therapeutics, Inc. $37.62 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613344
Principal investigator 1 Sarepta Therapeutics, Inc. $214.75 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613346
Principal investigator 1 Sarepta Therapeutics, Inc. $36.75 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613348
Principal investigator 1 Sarepta Therapeutics, Inc. $277.41 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613350
Principal investigator 1 Sarepta Therapeutics, Inc. $236.40 10/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613352
Principal investigator 1 Biogen, Inc. $89,381.00 10/13/2025 Non-covered Recipient Entity
CHKD Main Hospital
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old No dispute reported 06/30/2026 1236946972
Principal investigator 1 Sarepta Therapeutics, Inc. $2,422.09 10/06/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223616074
Principal investigator 1 Sarepta Therapeutics, Inc. $2,155.64 10/03/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613356
Principal investigator 1 Sarepta Therapeutics, Inc. $1,323.00 10/03/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613358
Principal investigator 1 Novartis Pharmaceuticals Corporation $4,164.00 10/01/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy No dispute reported 06/30/2026 1190305127
Principal investigator 1 PTC Therapeutics, Inc. $1,077.98 09/26/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093690
Principal investigator 1 Sarepta Therapeutics, Inc. $75.90 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223610465
Principal investigator 1 Sarepta Therapeutics, Inc. $86.58 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223610467
Principal investigator 1 Sarepta Therapeutics, Inc. $18.02 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615882
Principal investigator 1 Sarepta Therapeutics, Inc. $78.57 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615884
Principal investigator 1 Sarepta Therapeutics, Inc. $13.71 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615886
Principal investigator 1 Sarepta Therapeutics, Inc. $32.52 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615888
Principal investigator 1 Sarepta Therapeutics, Inc. $56.46 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615890
Principal investigator 1 Sarepta Therapeutics, Inc. $18.81 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615892
Principal investigator 1 Sarepta Therapeutics, Inc. $539.85 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615894
Principal investigator 1 Sarepta Therapeutics, Inc. $36.75 09/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223615896
Principal investigator 1 Sarepta Therapeutics, Inc. $9.60 09/15/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610461
Principal investigator 1 Sarepta Therapeutics, Inc. $58.88 09/15/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610463
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 09/15/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614029
Principal investigator 1 Sarepta Therapeutics, Inc. $7,158.78 09/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9003-301 No dispute reported 06/30/2026 1223612553
Principal investigator 1 PTC Therapeutics, Inc. $1,077.98 08/29/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093647
Principal investigator 1 PTC Therapeutics, Inc. $705.00 08/29/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093649
Principal investigator 1 Genentech, Inc. $2,921.54 08/27/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
A PHASE II STUDY OF SATRALIZUMAB IN PEDIATRIC PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY No dispute reported 06/30/2026 1211586291
Principal investigator 1 Sarepta Therapeutics, Inc. $1,883.05 08/25/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614953
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 08/25/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614957
Principal investigator 1 Sarepta Therapeutics, Inc. $110.25 08/22/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223614939
Principal investigator 1 Sarepta Therapeutics, Inc. $2,695.53 08/20/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-LGMD-501-NHS No dispute reported 06/30/2026 1223611465
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 08/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223614955
Principal investigator 1 Sarepta Therapeutics, Inc. $9,672.11 08/06/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223611543
Principal investigator 1 Sarepta Therapeutics, Inc. $26,666.15 07/31/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223609527
Principal investigator 1 PTC Therapeutics, Inc. $1,040.00 07/26/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093565
Principal investigator 1 Sarepta Therapeutics, Inc. $1,834.65 07/25/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-401 No dispute reported 06/30/2026 1223612531
Principal investigator 1 Sarepta Therapeutics, Inc. $10,125.00 07/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9005-101 No dispute reported 06/30/2026 1223611567
Principal investigator 1 Sarepta Therapeutics, Inc. $3,375.00 07/23/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9005-101 No dispute reported 06/30/2026 1223611569
Principal investigator 1 CSL Behring $1,000.00 07/14/2025 Non-covered Recipient Entity
Children'S Specialty Group, Pllc
Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP No dispute reported 06/30/2026 1252667135
Principal investigator 1 CSL Behring $1,250.00 07/14/2025 Non-covered Recipient Entity
Children'S Specialty Group, Pllc
Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP No dispute reported 06/30/2026 1252667137
Principal investigator 1 Sarepta Therapeutics, Inc. $0.24 07/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612453
Principal investigator 1 Sarepta Therapeutics, Inc. $0.28 07/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612455
Principal investigator 1 Sarepta Therapeutics, Inc. $0.02 07/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612457
Principal investigator 1 Sarepta Therapeutics, Inc. $9.60 07/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612459
Principal investigator 1 Sarepta Therapeutics, Inc. $29.44 07/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612461
Principal investigator 1 Genentech, Inc. $16,139.00 07/11/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
A PHASE II STUDY OF SATRALIZUMAB IN PEDIATRIC PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY No dispute reported 06/30/2026 1211586287
Principal investigator 1 Sarepta Therapeutics, Inc. $81,807.88 07/11/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9003-301 No dispute reported 06/30/2026 1223611467
Principal investigator 1 Sarepta Therapeutics, Inc. $240.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609515
Principal investigator 1 Sarepta Therapeutics, Inc. $240.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609517
Principal investigator 1 Sarepta Therapeutics, Inc. $240.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609519
Principal investigator 1 Sarepta Therapeutics, Inc. $240.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609521
Principal investigator 1 Sarepta Therapeutics, Inc. $240.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609523
Principal investigator 1 Sarepta Therapeutics, Inc. $240.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609525
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609529
Principal investigator 1 Sarepta Therapeutics, Inc. $95.76 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609531
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609533
Principal investigator 1 Sarepta Therapeutics, Inc. $95.76 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609535
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609537
Principal investigator 1 Sarepta Therapeutics, Inc. $95.81 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609539
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609541
Principal investigator 1 Sarepta Therapeutics, Inc. $95.76 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609543
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609545
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609547
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609549
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609551
Principal investigator 1 Sarepta Therapeutics, Inc. $95.76 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609553
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609555
Principal investigator 1 Sarepta Therapeutics, Inc. $95.76 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609557
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609559
Principal investigator 1 Sarepta Therapeutics, Inc. $81.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223615834
Principal investigator 1 Sarepta Therapeutics, Inc. $337.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223615836
Principal investigator 1 Sarepta Therapeutics, Inc. $240.00 07/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223615838
Principal investigator 1 Novartis Pharmaceuticals Corporation $4,197.00 07/09/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy No dispute reported 06/30/2026 1190305129
Principal investigator 1 Sarepta Therapeutics, Inc. $2,936.25 07/07/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223615770
Principal investigator 1 Sarepta Therapeutics, Inc. $945.00 07/07/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223615772
Principal investigator 1 Sarepta Therapeutics, Inc. $337.00 07/07/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223615774
Principal investigator 1 Sarepta Therapeutics, Inc. $767.48 07/07/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223615776
Principal investigator 1 PTC Therapeutics, Inc. $2,386.26 06/30/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093455
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 06/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613081
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 06/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611323
Principal investigator 1 Sarepta Therapeutics, Inc. $38,281.18 06/20/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223611143
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/18/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611315
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/18/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611333
Principal investigator 1 Sarepta Therapeutics, Inc. $0.24 06/11/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612927
Principal investigator 1 Sarepta Therapeutics, Inc. $0.28 06/11/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612929
Principal investigator 1 Sarepta Therapeutics, Inc. $0.02 06/11/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612931
Principal investigator 1 Sarepta Therapeutics, Inc. $9.26 06/11/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612933
Principal investigator 1 Sarepta Therapeutics, Inc. $59.14 06/11/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612935
Principal investigator 1 Sarepta Therapeutics, Inc. $1,524.07 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611305
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611307
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611309
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611311
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611313
Principal investigator 1 Sarepta Therapeutics, Inc. $3,812.71 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611317
Principal investigator 1 Sarepta Therapeutics, Inc. $2,422.09 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611321
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611325
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611327
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611331
Principal investigator 1 Sarepta Therapeutics, Inc. $1,524.07 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613079
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613083
Principal investigator 1 Sarepta Therapeutics, Inc. $26,666.15 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613085
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613087
Principal investigator 1 Sarepta Therapeutics, Inc. $3,812.71 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613093
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613095
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/02/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611319
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 06/02/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611329
Principal investigator 1 Sarepta Therapeutics, Inc. $817.39 06/02/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223613089
Principal investigator 1 Sarepta Therapeutics, Inc. $630.00 06/02/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223613091
Principal investigator 1 PTC Therapeutics, Inc. $1,223.78 05/30/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093417
Principal investigator 1 Sarepta Therapeutics, Inc. $6,472.82 05/26/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223611239
Principal investigator 1 Sarepta Therapeutics, Inc. $6,472.82 05/26/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223611243
Principal investigator 1 Novartis Pharmaceuticals Corporation $5,500.00 05/22/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP
Phase IIIb, Open-label, Single-arm, Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally (1.2 x 10^14 Vector Genomes) to Participants 2 to 12 Years of Age With Spinal Muscular Atrophy (SMA) Who Have Dis No dispute reported 06/30/2026 1190300235
Principal investigator 1 Sarepta Therapeutics, Inc. $2,751.97 05/21/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-401 No dispute reported 06/30/2026 1223612961
Principal investigator 1 Sarepta Therapeutics, Inc. $12.62 05/20/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223613989
Principal investigator 1 Sarepta Therapeutics, Inc. $0.36 05/16/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223613973
Principal investigator 1 Sarepta Therapeutics, Inc. $0.42 05/16/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223613975
Principal investigator 1 Sarepta Therapeutics, Inc. $0.03 05/16/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223613977
Principal investigator 1 Sarepta Therapeutics, Inc. $13.89 05/16/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223613979
Principal investigator 1 Sarepta Therapeutics, Inc. $88.71 05/16/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223613981
Principal investigator 1 Sarepta Therapeutics, Inc. $22.90 05/15/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613983
Principal investigator 1 Sarepta Therapeutics, Inc. $166.88 05/15/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613985
Principal investigator 1 Sarepta Therapeutics, Inc. $30.42 05/15/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613987
Principal investigator 1 Sarepta Therapeutics, Inc. $1,000.00 05/07/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223611241
Principal investigator 1 Sarepta Therapeutics, Inc. $1,304.85 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612177
Principal investigator 1 Sarepta Therapeutics, Inc. $11,455.69 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612179
Principal investigator 1 Sarepta Therapeutics, Inc. $1,394.26 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612181
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612183
Principal investigator 1 Sarepta Therapeutics, Inc. $1,304.85 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612185
Principal investigator 1 Sarepta Therapeutics, Inc. $916.99 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223612187
Principal investigator 1 Sarepta Therapeutics, Inc. $9,846.87 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612189
Principal investigator 1 Sarepta Therapeutics, Inc. $1,685.00 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612191
Principal investigator 1 Sarepta Therapeutics, Inc. $1,438.85 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612193
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613919
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613921
Principal investigator 1 Sarepta Therapeutics, Inc. $1,079.14 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613923
Principal investigator 1 Sarepta Therapeutics, Inc. $504.91 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613925
Principal investigator 1 Sarepta Therapeutics, Inc. $1,079.14 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613927
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613929
Principal investigator 1 Sarepta Therapeutics, Inc. $1,438.85 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613931
Principal investigator 1 Sarepta Therapeutics, Inc. $1,079.13 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613933
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613935
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613937
Principal investigator 1 Sarepta Therapeutics, Inc. $26,666.15 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613939
Principal investigator 1 Sarepta Therapeutics, Inc. $809.34 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613941
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613943
Principal investigator 1 Sarepta Therapeutics, Inc. $1,394.26 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613945
Principal investigator 1 Sarepta Therapeutics, Inc. $1,524.07 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613947
Principal investigator 1 Sarepta Therapeutics, Inc. $9,846.87 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613949
Principal investigator 1 Sarepta Therapeutics, Inc. $809.34 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613951
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613953
Principal investigator 1 Sarepta Therapeutics, Inc. $1,079.14 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223613955
Principal investigator 1 Sarepta Therapeutics, Inc. $11,455.69 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223615573
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223615575
Principal investigator 1 Sarepta Therapeutics, Inc. $1,079.14 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223615577
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223615579
Principal investigator 1 Sarepta Therapeutics, Inc. $11,455.69 04/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223615581
Principal investigator 1 Sarepta Therapeutics, Inc. $37.37 04/28/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-103 No dispute reported 06/30/2026 1223610291
Principal investigator 1 Alexion Pharmaceuticals, Inc. $77,344.33 04/10/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP, PLLC
An Open-Label, Single-arm Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, and Efficacy of Gefurulimab in Pediatric Patients (6 to < 18 years of age) with Generalized Myasthenia Gravis (gMG) Who Express Acetylcholine Receptor Antibodies (AChR+) No dispute reported 06/30/2026 1185553665
Recipient F. Hoffmann-La Roche AG $965.12 03/31/2025 Covered Recipient Physician A PHASE II STUDY OF SATRALIZUMAB IN PEDIATRIC PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY No dispute reported 06/30/2026 1211535229
Recipient F. Hoffmann-La Roche AG $435.13 03/31/2025 Covered Recipient Physician A PHASE II STUDY OF SATRALIZUMAB IN PEDIATRIC PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY No dispute reported 06/30/2026 1211535233
Principal investigator 1 Sarepta Therapeutics, Inc. $16,956.54 03/26/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9003-301 No dispute reported 06/30/2026 1223609027
Principal investigator 1 Sarepta Therapeutics, Inc. $6.18 03/26/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223609113
Principal investigator 1 Sarepta Therapeutics, Inc. $85.38 03/26/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223609115
Principal investigator 1 Sarepta Therapeutics, Inc. $18.31 03/26/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223609117
Principal investigator 1 Sarepta Therapeutics, Inc. $4.57 03/26/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223609119
Principal investigator 1 Sarepta Therapeutics, Inc. $916.99 03/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609971
Principal investigator 1 Sarepta Therapeutics, Inc. $916.99 03/24/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223609973
Principal investigator 1 PTC Therapeutics, Inc. $2,395.00 03/17/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093275
Recipient Novartis Pharma AG $212.44 03/15/2025 Covered Recipient Physician COAV101A12001 No dispute reported 06/30/2026 1248109681
Principal investigator 1 Sarepta Therapeutics, Inc. $10,346.73 03/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-LGMD-501-NHS No dispute reported 06/30/2026 1223609023
Principal investigator 1 Sarepta Therapeutics, Inc. $8,022.10 03/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-LGMD-501-NHS No dispute reported 06/30/2026 1223609025
Principal investigator 1 Sarepta Therapeutics, Inc. $7,255.42 03/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-LGMD-501-NHS No dispute reported 06/30/2026 1223615358
Principal investigator 1 Sarepta Therapeutics, Inc. $62,283.70 03/03/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223609029
Principal investigator 1 Sarepta Therapeutics, Inc. $2,323.39 02/28/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223611939
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,022.00 02/27/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP
A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101 No dispute reported 06/30/2026 1190308700
Principal investigator 1 PTC Therapeutics, Inc. $470.00 02/27/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249093221
Principal investigator 1 Sarepta Therapeutics, Inc. $0.24 02/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223611941
Principal investigator 1 Sarepta Therapeutics, Inc. $0.28 02/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223611943
Principal investigator 1 Sarepta Therapeutics, Inc. $0.02 02/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223611945
Principal investigator 1 Sarepta Therapeutics, Inc. $65.46 02/14/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223611947
Principal investigator 1 Biogen, Inc. $72,686.80 02/12/2025 Non-covered Recipient Entity
CHKD Main Hospital
An Open Label, Single Cohort Study to Assess the Pharmacokinetic Profile of Nusinersen (BIIB058) Administered Via the ThecaFlex DRx System (PIERRE-PK) No dispute reported 06/30/2026 1236947274
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612773
Principal investigator 1 Sarepta Therapeutics, Inc. $1,394.26 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612775
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612777
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612779
Principal investigator 1 Sarepta Therapeutics, Inc. $3,812.71 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612781
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612783
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612785
Principal investigator 1 Sarepta Therapeutics, Inc. $1,304.85 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612787
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612789
Principal investigator 1 Sarepta Therapeutics, Inc. $321.66 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612791
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612793
Principal investigator 1 Sarepta Therapeutics, Inc. $418.29 02/05/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223612795
Principal investigator 1 Genentech, Inc. $16,875.00 01/30/2025 Non-covered Recipient Entity
Childrens Specialty Group PLLC
Risdiplam post gene therapy study treatment prophylactically study 1 No dispute reported 06/30/2026 1211586299
Recipient Novartis Pharmaceuticals Corporation $9,621.58 01/30/2025 Covered Recipient Physician STEER No dispute reported 06/30/2026 1190293712
Principal investigator 1 Sarepta Therapeutics, Inc. $916.99 01/30/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223614499
Principal investigator 1 Sarepta Therapeutics, Inc. $17,297.05 01/29/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9004-102 No dispute reported 06/30/2026 1223609031
Principal investigator 1 Sarepta Therapeutics, Inc. $2,085.39 01/29/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223614493
Principal investigator 1 Sarepta Therapeutics, Inc. $916.99 01/29/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223614495
Principal investigator 1 Genentech, Inc. $15,525.00 01/28/2025 Non-covered Recipient Entity
Childrens Specialty Group PLLC
A PHASE II STUDY OF SATRALIZUMAB IN PEDIATRIC PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY No dispute reported 06/30/2026 1211586283
Principal investigator 1 Sarepta Therapeutics, Inc. $1.00 01/28/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610029
Principal investigator 1 Sarepta Therapeutics, Inc. $256.14 01/28/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610031
Principal investigator 1 Sarepta Therapeutics, Inc. $893.52 01/27/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-303 No dispute reported 06/30/2026 1223610019
Principal investigator 1 Sarepta Therapeutics, Inc. $0.72 01/27/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610021
Principal investigator 1 Sarepta Therapeutics, Inc. $0.84 01/27/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610023
Principal investigator 1 Sarepta Therapeutics, Inc. $0.06 01/27/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610025
Principal investigator 1 Sarepta Therapeutics, Inc. $98.19 01/27/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610027
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,565.50 01/23/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy No dispute reported 06/30/2026 1190305125
Principal investigator 1 Sarepta Therapeutics, Inc. $6,472.82 01/10/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223614497
Principal investigator 1 Sarepta Therapeutics, Inc. $630.00 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614489
Principal investigator 1 Sarepta Therapeutics, Inc. $506.72 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614491
Principal investigator 1 Sarepta Therapeutics, Inc. $194.14 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614501
Principal investigator 1 Sarepta Therapeutics, Inc. $194.14 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614503
Principal investigator 1 Sarepta Therapeutics, Inc. $203.78 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614505
Principal investigator 1 Sarepta Therapeutics, Inc. $570.06 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614507
Principal investigator 1 Sarepta Therapeutics, Inc. $594.78 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614509
Principal investigator 1 Sarepta Therapeutics, Inc. $203.78 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614511
Principal investigator 1 Sarepta Therapeutics, Inc. $61.95 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614513
Principal investigator 1 Sarepta Therapeutics, Inc. $203.78 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614515
Principal investigator 1 Sarepta Therapeutics, Inc. $467.09 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614517
Principal investigator 1 Sarepta Therapeutics, Inc. $433.68 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614519
Principal investigator 1 Sarepta Therapeutics, Inc. $570.06 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614521
Principal investigator 1 Sarepta Therapeutics, Inc. $467.09 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614523
Principal investigator 1 Sarepta Therapeutics, Inc. $945.00 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614525
Principal investigator 1 Sarepta Therapeutics, Inc. $61.95 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614527
Principal investigator 1 Sarepta Therapeutics, Inc. $61.95 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614529
Principal investigator 1 Sarepta Therapeutics, Inc. $194.14 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614531
Principal investigator 1 Sarepta Therapeutics, Inc. $495.63 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223614533
Principal investigator 1 Sarepta Therapeutics, Inc. $557.59 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615360
Principal investigator 1 Sarepta Therapeutics, Inc. $557.59 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615362
Principal investigator 1 Sarepta Therapeutics, Inc. $594.78 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615364
Principal investigator 1 Sarepta Therapeutics, Inc. $5,355.00 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615366
Principal investigator 1 Sarepta Therapeutics, Inc. $61.95 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615368
Principal investigator 1 Sarepta Therapeutics, Inc. $557.59 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615370
Principal investigator 1 Sarepta Therapeutics, Inc. $528.70 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615372
Principal investigator 1 Sarepta Therapeutics, Inc. $194.14 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615374
Principal investigator 1 Sarepta Therapeutics, Inc. $570.06 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615376
Principal investigator 1 Sarepta Therapeutics, Inc. $594.78 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615378
Principal investigator 1 Sarepta Therapeutics, Inc. $467.09 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615380
Principal investigator 1 Sarepta Therapeutics, Inc. $203.82 01/09/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-301 No dispute reported 06/30/2026 1223615382
Principal investigator 1 Biogen, Inc. $1,369.00 01/07/2025 Covered Recipient Teaching Hospital
Childrens Hospital Of The Kings Da
A Phase 4 Study of Nusinersen (BIIB058) Among Patients With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec No dispute reported 06/30/2026 1236947602
Principal investigator 1 Sarepta Therapeutics, Inc. $425.26 01/07/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610015
Principal investigator 1 Sarepta Therapeutics, Inc. $18.96 01/07/2025 Non-covered Recipient Entity
CHILDREN'S SPECIALTY GROUP, PLLC
SRP-9001-305 No dispute reported 06/30/2026 1223610017
Principal investigator 1 Novartis Pharmaceuticals Corporation $10,269.00 01/01/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials No dispute reported 06/30/2026 1190305133
Principal investigator 1 Novartis Pharmaceuticals Corporation $3,176.90 01/01/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
A Randomized, Sham-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Intrathecal OAV101 in Patients Type 2 Spinal Muscular Atrophy (SMA) Who Are 2 to < 18 Years of Age, Treatment Naive, Sitting, and Never Ambulatory No dispute reported 06/30/2026 1190305135
Principal investigator 1 Novartis Pharmaceuticals Corporation $805.30 01/01/2025 Non-covered Recipient Entity
CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
Phase IIIb, Open-label, Single-arm, Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally (1.2 x 10^14 Vector Genomes) to Participants 2 to 12 Years of Age With Spinal Muscular Atrophy (SMA) Who Have Dis No dispute reported 06/30/2026 1190305139
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $45,473.65 01/01/2025 Non-covered Recipient Entity
CHILDRENS SPECIALTY GROUP PLLC
A Phase 1/2, Randomized, Double-blind, Placebo?controlled Single- and Multiple?dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VX?670 in Adult Subjects with Myotonic Dystrophy Type 1 No dispute reported 06/30/2026 1214123812